For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog
Not necessarily dangerous, but it needs medical oversight and close glucose monitoring
More weight-loss medications are on the way
Handling & storage Store the pen refrigerated at 28C, protect it from light, and keep it within the storage window printed on the COA
Then, inspired by her moms success with semaglutide (Wegovy) one of the glucagonlike peptide-1 (GLP-1) medications thats been transforming weight-loss care Frankie got a prescription as well
Disclosure: This article contains affiliate links